Literature DB >> 10424790

Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast.

J S Chu1, K J Chang.   

Abstract

To investigate mucin expression in breast cancer, immunohistochemical staining was performed on 30 mucinous carcinomas and 95 non-mucinous invasive carcinomas. MUC2 expression was detected in all mucinous carcinomas, but only in 11.1% of invasive ductal carcinomas, and in none of the invasive lobular carcinomas and medullary carcinomas. MUC1 is often expressed in invasive breast carcinoma, but not in medullary carcinoma. Strong cytoplasmic staining was seen in invasive ductal carcinoma, in contrast to surface membrane staining in mucinous carcinoma and intracytoplasmic vacuole staining in invasive lobular carcinoma. CA19-9 and CA50 expression in more than 25% of tumor cells was seen in 17.2 and 16.0% of invasive ductal carcinomas, respectively, but not in mucinous carcinomas. CA125 and human gastric mucin were rarely expressed in breast cancer, irrespective of histologic type.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424790     DOI: 10.1016/s0304-3835(99)00161-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.

Authors:  Anna Astashchanka; Thomas M Shroka; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2018-10-13       Impact factor: 4.872

2.  Meningeal carcinomatosis preceded by a rapid increase in serum CA19-9 levels in a patient with breast cancer.

Authors:  Kazuo Yasumoto; Yutaka Takahashi; Masayoshi Mai; Atsuhiro Kawashima
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

3.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

4.  Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.

Authors:  Jing Yu; Rohit Bhargava; David J Dabbs
Journal:  Diagn Pathol       Date:  2010-06-15       Impact factor: 2.644

5.  Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.

Authors:  Michael D Walsh; Margaret C Cummings; Sally-Ann Pearson; Mark Clendenning; Rhiannon J Walters; Belinda Nagler; John L Hopper; Mark A Jenkins; Graeme K Suthers; Jack Goldblatt; Kathy Tucker; Michael R Gattas; Julie L Arnold; Susan Parry; Finlay A Macrae; Michael A McGuckin; Joanne P Young; Daniel D Buchanan
Journal:  Mod Pathol       Date:  2013-02-01       Impact factor: 7.842

6.  Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.

Authors:  Subrata K Ghosh; Pamela Pantazopoulos; Zdravka Medarova; Anna Moore
Journal:  Clin Breast Cancer       Date:  2012-11-01       Impact factor: 3.225

7.  Targeting Underglycosylated MUC1 for the Selective Capture of Highly Metastatic Breast Cancer Cells Under Flow.

Authors:  Yue Geng; Tait Takatani; Kimberly Yeh; Jong-Wei Hsu; Michael R King
Journal:  Cell Mol Bioeng       Date:  2013-05-22       Impact factor: 2.321

8.  Differential expression of MUC genes in endometrial and cervical tissues and tumors.

Authors:  Vidya Hebbar; Gautam Damera; Goverdhan P Sachdev
Journal:  BMC Cancer       Date:  2005-09-27       Impact factor: 4.430

9.  In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.

Authors:  Chanel E Smart; Brian J Morrison; Jodi M Saunus; Ana Cristina Vargas; Patricia Keith; Lynne Reid; Leesa Wockner; Marjan Askarian-Amiri; Marjan Askarian Amiri; Debina Sarkar; Peter T Simpson; Catherine Clarke; Chris W Schmidt; Brent A Reynolds; Sunil R Lakhani; J Alejandro Lopez
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

10.  Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft.

Authors:  M-E Legrier; G de Pinieux; K Boyé; F Arvelo; J-G Judde; J-J Fontaine; J Bara; M-F Poupon
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.